RRML - Myelodysplastic syndrome with myelofibrosis in a 12-year-old patient – A case report
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English


Clarivate analytics (ISI) Impact factor


Advanced search


Top 10 downloaded articles
- September 2020 -
 
Romanian Review of Laboratory ... 21
Metabolomic biomarkers of poly... 13
Variability of ex-vivo stimula... 8
The association of anthropomet... 8
Role of fecal calprotectin as ... 6
The predictive role of platele... 6
Antibacterial and antitumor ac... 6
FLT-3 ITD Positive Acute Basop... 5
Implications of visfatin genet... 5
Characterization of antibiotic... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 26(1)/2018 DOI:10.1515/rrlm-2017-0034
XML
TXT

Case report

Myelodysplastic syndrome with myelofibrosis in a 12-year-old patient – A case report

Andreea Oltean, Mihaela Ioana Chincesan, Oana Marginean, Emoke Horvath

Correspondence should be addressed to: Mihaela Ioana Chincesan

Abstract:

Myelodysplastic syndromes are a heterogeneous group of clonal disorders characterized by peripheral blood cytopenia and normal or hypercellular bone marrow with dysplasia in more than one blood cell lineage, unfavorable prognosis, and lack of response to treatment. We present the case of a 12-year-old male patient who was referred to the Hematology and Oncology Department of Pediatric Clinic I Târgu- Mures in May 2016, with splenomegaly and pancytopenia. The osteomedullary biopsy revealed myelofibrosis, discrete dysplasia of the myeloid series and megakaryocytes, blasts CD34+ approximately 10%, which led to the diagnosis of myelodysplastic syndrome with myelofibrosis. The myeloid precursors indicated a high risk of transformation into acute myeloid leukemia, so chemotherapy associated with corticosteroids was started, leading to slight improvements.
 Although myelodysplastic syndrome associated with myelofibrosis is rare at this age, despite the treatment and favorable progression in the case presented, in the absence of hematopoietic stem cell transplantation the prognosis remains unfavorable.

Keywords: myelodysplastic syndrome, pancytopenia, myelofibrosis, children

Received: 6.7.2017
Accepted: 18.10.2017
Published: 22.11.2017

 
  PDF Download full text PDF
(1749 KB)
     
 
How to cite
Oltean A, Chincesan MI, Marginean O, Horvath E. Myelodysplastic syndrome with myelofibrosis in a 12-year-old patient – A case report. Rev Romana Med Lab. 2018;26(1):95-103. DOI:10.1515/rrlm-2017-0034